How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis
- PMID: 16570014
- DOI: 10.1097/01.tp.0000185197.37824.35
How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis
Abstract
Background: In a large patient cohort, we investigated long-term corneal graft outcome, risk factors for graft failure, and whether corneal graft survival had improved over time.
Methods: Records of 10,952 full-thickness corneal grafts with associated archival follow-up were examined within a prospectively-maintained, national database of 13,831 records, with follow-up extending for up to 18 years. Kaplan-Meier survival analysis was used to indicate variables of interest for Cox proportional hazards regression analysis. A model clustered by individual patient to control for inter-eye or inter-graft dependence was constructed to identify variables best predicting penetrating corneal graft failure.
Results: Probability of corneal graft survival was 0.86 at 1 year, 0.73 at 5 years, 0.62 at 10 years, and 0.55 at 15 years. Graft survival did not improve over a 15-year timeframe. Variables predicting graft failure in multivariate analysis included transplant centre, donor age, preoperative diagnosis, number of previous ipsilateral grafts, lens status, history of corneal neovascularisation, ocular inflammation or raised intraocular pressure in the grafted eye, requirement for anterior vitrectomy, graft size, early suture removal, postoperative events including graft neovascularisation, rise in intraocular pressure, and rejection episodes, type of treatment for raised intraocular pressure, and arrangements for recipient follow-up. A further 11 variables showing a significant influence on graft survival in univariate analysis were not included in the final Cox model.
Conclusion: The long-term results of corneal transplantation are no better than for other forms of transplantation and have shown no measurable improvement over the past 15 years.
Similar articles
-
Risk factors for human corneal graft failure within the Australian corneal graft registry.Transplantation. 2008 Dec 27;86(12):1720-4. doi: 10.1097/TP.0b013e3181903b0a. Transplantation. 2008. PMID: 19104411
-
The Australian Corneal Graft Registry. 1990 to 1992 report.Aust N Z J Ophthalmol. 1993 May;21(2 Suppl):1-48. Aust N Z J Ophthalmol. 1993. PMID: 8333942 Review.
-
Penetrating keratoplasty in Asian eyes: the Singapore Corneal Transplant Study.Ophthalmology. 2008 Jun;115(6):975-982.e1. doi: 10.1016/j.ophtha.2007.08.049. Epub 2007 Dec 3. Ophthalmology. 2008. PMID: 18061267
-
Repeat penetrating corneal transplantation in patients with keratoconus.Ophthalmology. 2011 Aug;118(8):1538-42. doi: 10.1016/j.ophtha.2011.01.002. Epub 2011 Apr 3. Ophthalmology. 2011. PMID: 21459452
-
The impact of corneal allograft rejection on the long-term outcome of corneal transplantation.Am J Ophthalmol. 2005 Dec;140(6):1112-22. doi: 10.1016/j.ajo.2005.07.024. Am J Ophthalmol. 2005. PMID: 16376660 Review.
Cited by
-
Outcome of repeat penetrating keratoplasty in eyes with failed penetrating keratoplasty.Saudi Med J. 2016 Sep;37(9):1029-32. doi: 10.15537/smj.2016.9.14075. Saudi Med J. 2016. PMID: 27570862 Free PMC article.
-
Dental pulp stem cells: a new cellular resource for corneal stromal regeneration.Stem Cells Transl Med. 2015 Mar;4(3):276-85. doi: 10.5966/sctm.2014-0115. Stem Cells Transl Med. 2015. PMID: 25713466 Free PMC article.
-
Bevacizumab in High-Risk Corneal Transplantation: A Pilot Multicenter Prospective Randomized Control Trial.Ophthalmology. 2022 Aug;129(8):865-879. doi: 10.1016/j.ophtha.2022.03.024. Epub 2022 Mar 28. Ophthalmology. 2022. PMID: 35358592 Free PMC article. Clinical Trial.
-
Different Murine High-Risk Corneal Transplant Settings Vary Significantly in Their (Lymph)angiogenic and Inflammatory Cell Signatures.Invest Ophthalmol Vis Sci. 2022 Dec 1;63(13):18. doi: 10.1167/iovs.63.13.18. Invest Ophthalmol Vis Sci. 2022. PMID: 36534386 Free PMC article.
-
Corneal Stem Cells as a Source of Regenerative Cell-Based Therapy.Stem Cells Int. 2020 Jul 20;2020:8813447. doi: 10.1155/2020/8813447. eCollection 2020. Stem Cells Int. 2020. PMID: 32765614 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous